Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Goldman

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
The Journal of Antimicrobial Chemotherapy|April 9, 1998
Molecular basis of clarithromycin activity against Mycobacterium avium and Mycobacterium smegmatisF Doucet-Populaire, J O Capobianco, D Zakula, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1996
Analysis of the sugar specificity and molecular location of the beta-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18)B P Thornton, V Vĕtvicka, M Pitman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1983
Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavageK A Joiner, R C Goldman, C H Hammer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1983
Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 depositionK A Joiner, R C Goldman, C H Hammer, et al.
Infection and Immunity|July 1, 1984
Mechanism of bacterial resistance to complement-mediated killing: inserted C5b-9 correlates with killing for Escherichia coli O111B4 varying in O-antigen capsule and O-polysaccharide coverage of lipid A core oligosaccharideK A Joiner, M A Schmetz, R C Goldman, et al.
The Journal of Biological Chemistry|December 5, 1986
Primary structure of CTP:CMP-3-deoxy-D-manno-octulosonate cytidylyltransferase (CMP-KDO synthetase) from Escherichia coliR C Goldman, T J Bolling, W E Kohlbrenner, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1996
Inhibition of 2,3-oxidosqualene-lanosterol cyclase in Candida albicans by pyridinium ion-based inhibitorsR C Goldman, D Zakula, J O Capobianco, et al.
Journal of Bacteriology|September 1, 1987
Inhibition of exogenous 3-deoxy-D-manno-octulosonate incorporation into lipid A precursor of toluene-treated Salmonella typhimurium cellsJ O Capobianco, R P Darveau, R C Goldman, et al.
Infectious Agents and Disease|December 1, 1995
Antifungal drug targets: Candida secreted aspartyl protease and fungal wall beta-glucan synthesisR C Goldman, D J Frost, J O Capobianco, et al.
Antimicrobial Agents and Chemotherapy|April 4, 1998
Cellular accumulation, localization, and activity of a synthetic cyclopeptamine in fungiJ O Capobianco, D Zakula, D J Frost, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
The Journal of Antimicrobial Chemotherapy|April 9, 1998
Molecular basis of clarithromycin activity against Mycobacterium avium and Mycobacterium smegmatisF Doucet-Populaire, J O Capobianco, D Zakula, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1996
Analysis of the sugar specificity and molecular location of the beta-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18)B P Thornton, V Vĕtvicka, M Pitman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1983
Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavageK A Joiner, R C Goldman, C H Hammer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1983
Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 depositionK A Joiner, R C Goldman, C H Hammer, et al.
Infection and Immunity|July 1, 1984
Mechanism of bacterial resistance to complement-mediated killing: inserted C5b-9 correlates with killing for Escherichia coli O111B4 varying in O-antigen capsule and O-polysaccharide coverage of lipid A core oligosaccharideK A Joiner, M A Schmetz, R C Goldman, et al.
The Journal of Biological Chemistry|December 5, 1986
Primary structure of CTP:CMP-3-deoxy-D-manno-octulosonate cytidylyltransferase (CMP-KDO synthetase) from Escherichia coliR C Goldman, T J Bolling, W E Kohlbrenner, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1996
Inhibition of 2,3-oxidosqualene-lanosterol cyclase in Candida albicans by pyridinium ion-based inhibitorsR C Goldman, D Zakula, J O Capobianco, et al.
Journal of Bacteriology|September 1, 1987
Inhibition of exogenous 3-deoxy-D-manno-octulosonate incorporation into lipid A precursor of toluene-treated Salmonella typhimurium cellsJ O Capobianco, R P Darveau, R C Goldman, et al.
Infectious Agents and Disease|December 1, 1995
Antifungal drug targets: Candida secreted aspartyl protease and fungal wall beta-glucan synthesisR C Goldman, D J Frost, J O Capobianco, et al.
Antimicrobial Agents and Chemotherapy|April 4, 1998
Cellular accumulation, localization, and activity of a synthetic cyclopeptamine in fungiJ O Capobianco, D Zakula, D J Frost, et al.
Pageof 6